Yatai Group and its wholly-owned subsidiaries and holding subsidiaries recruit pre-restructuring investors

Recently, Yatai Group issued the Announcement of Jilin Yatai (Group) Co., Ltd. on the Recruitment of Investors for the Pre-reorganization of the Company and its wholly-owned subsidiaries and holding subsidiaries. According to

the announcement, In order to smoothly promote Jilin Yatai (Group) Co., Ltd. (Hereinafter referred to as the "Company" or "Yatai Group") and its subsidiaries Yatai Pharmaceutical Group Co., Ltd., Jilin Northeast Asia Pharmaceutical Co., Ltd., Jilin Longxin Pharmaceutical Co., Ltd., Jilin Pharmacy Pharmaceutical Co., Ltd., The pre-reorganization of Jilin Yatai Pharmaceutical Logistics Co., Ltd. (Hereinafter collectively referred to as the "Five Pharmaceutical Subsidiaries") will restore and enhance the company's sustainable operation and profitability, safeguard the legitimate rights and interests of creditors and minority shareholders, and the temporary administrator will publicly recruit reorganization investors. On July 17

, 2026, the creditors of the company and its five pharmaceutical subsidiaries applied to the Changchun Intermediate Court for reorganization of Yatai Group and its five pharmaceutical subsidiaries, and at the same time applied for pre-reorganization. On July 28, 2026, the Changchun Intermediate People's Court issued the Decision (2026) Ji 01 Po Shen No.29 to No.34, deciding to pre-restructure Yatai Group and its five pharmaceutical subsidiaries, and appointed the liquidation team of Yatai Group as the temporary administrator of Yatai Group and its five pharmaceutical subsidiaries on the same day.